TrialInternational journal of cancer2013

A dose-finding study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcoma.

K A Thornton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.